Management of Community-Acquired Pneumonia in Patients with Comorbidities
Hospital Admission Criteria
- The British Thoracic Society guidelines recommend hospital admission for patients with comorbidities like diabetes, as they require closer monitoring and are at a higher risk of complications 1, 3
- Patients with a smoking history are at a higher risk of underlying chronic lung disease and malignancy, requiring hospital admission for closer monitoring 1, 2, 4
Antibiotic Selection
- The British Thoracic Society guidelines recommend combination therapy with a beta-lactam plus macrolide for hospitalized patients with non-severe to moderate community-acquired pneumonia (CAP) and comorbidities 1, 3
- Ceftriaxone provides broad-spectrum coverage against typical bacterial pathogens, including Streptococcus pneumoniae and Haemophilus influenzae 1
- Azithromycin covers atypical pathogens, including Mycoplasma pneumoniae and Chlamydophila pneumoniae 1, 3
Route of Administration
- Intravenous antibiotics are indicated initially for hospitalized patients with CAP and comorbidities 1
- Early switch to oral therapy should occur once the patient is clinically stable, as indicated by being afebrile, improvement in cough and dyspnea, decreasing white blood cell count, and functioning GI tract 5, 6
Critical Monitoring Parameters
- Monitor temperature, respiratory rate, pulse, blood pressure, mental status, and oxygen saturation at least twice daily 2, 4, 7
- Reassess clinical response at 48-72 hours, and do not change antibiotics before 72 hours unless marked clinical deterioration or bacteriologic data necessitate change 5, 7